ATE64468T1 - Verfahren zur optischen anzeige der direkten oder indirekten bestimmung der reaktion zwischen einem spezifischen bindungsmittel und der korrespondierenden akzeptorsubstanz in ''blot overlay''-testverfahren. - Google Patents

Verfahren zur optischen anzeige der direkten oder indirekten bestimmung der reaktion zwischen einem spezifischen bindungsmittel und der korrespondierenden akzeptorsubstanz in ''blot overlay''-testverfahren.

Info

Publication number
ATE64468T1
ATE64468T1 AT84201559T AT84201559T ATE64468T1 AT E64468 T1 ATE64468 T1 AT E64468T1 AT 84201559 T AT84201559 T AT 84201559T AT 84201559 T AT84201559 T AT 84201559T AT E64468 T1 ATE64468 T1 AT E64468T1
Authority
AT
Austria
Prior art keywords
methods
reaction
binding agent
specific binding
acceptor substance
Prior art date
Application number
AT84201559T
Other languages
English (en)
Inventor
Marc K J J Moeremans
Guido F T Daneels
Mey Jan R De
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE64468T1 publication Critical patent/ATE64468T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/559—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody through a gel, e.g. Ouchterlony technique
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Communication Control (AREA)
  • Details Of Television Scanning (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Conductive Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT84201559T 1983-11-25 1984-10-31 Verfahren zur optischen anzeige der direkten oder indirekten bestimmung der reaktion zwischen einem spezifischen bindungsmittel und der korrespondierenden akzeptorsubstanz in ''blot overlay''-testverfahren. ATE64468T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838331514A GB8331514D0 (en) 1983-11-25 1983-11-25 Visualization method
EP84201559A EP0158746B1 (de) 1983-11-25 1984-10-31 Verfahren zur optischen Anzeige der direkten oder indirekten Bestimmung der Reaktion zwischen einem spezifischen Bindungsmittel und der korrespondierenden Akzeptorsubstanz in "Blot overlay"-Testverfahren

Publications (1)

Publication Number Publication Date
ATE64468T1 true ATE64468T1 (de) 1991-06-15

Family

ID=10552346

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84201559T ATE64468T1 (de) 1983-11-25 1984-10-31 Verfahren zur optischen anzeige der direkten oder indirekten bestimmung der reaktion zwischen einem spezifischen bindungsmittel und der korrespondierenden akzeptorsubstanz in ''blot overlay''-testverfahren.

Country Status (19)

Country Link
US (1) US4775636A (de)
EP (1) EP0158746B1 (de)
JP (2) JPH0643998B2 (de)
KR (1) KR890001131B1 (de)
AT (1) ATE64468T1 (de)
AU (1) AU583484B2 (de)
CA (1) CA1253422A (de)
CY (1) CY1759A (de)
DE (1) DE3484710D1 (de)
DK (1) DK160108C (de)
ES (1) ES537926A0 (de)
FI (1) FI80345C (de)
GB (1) GB8331514D0 (de)
HK (1) HK14894A (de)
IL (1) IL73607A (de)
NO (1) NO163754C (de)
NZ (1) NZ210309A (de)
PT (1) PT79533A (de)
ZA (1) ZA849182B (de)

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
GB8415998D0 (en) * 1984-06-22 1984-07-25 Janssen Pharmaceutica Nv Staining method
US5958790A (en) * 1984-12-20 1999-09-28 Nycomed Imaging As Solid phase transverse diffusion assay
US5512332A (en) * 1985-10-04 1996-04-30 Immunivest Corporation Process of making resuspendable coated magnetic particles
US5137827A (en) * 1986-03-25 1992-08-11 Midwest Research Technologies, Inc. Diagnostic element for electrical detection of a binding reaction
US5514602A (en) * 1986-06-09 1996-05-07 Ortho Diagnostic Systems, Inc. Method of producing a metal sol reagent containing colloidal metal particles
AU602694B2 (en) * 1986-06-09 1990-10-25 Ortho Diagnostic Systems Inc. Improved colloidal gold membrane assay
US4837145A (en) * 1986-06-09 1989-06-06 Liotta Lance A Layered immunoassay using antibodies bound to transport particles to determine the presence of an antigen
AU7385387A (en) * 1986-06-09 1987-12-10 Ortho Diagnostic Systems Inc. Immunoassay using detection of colloidal gold
EP0254081A3 (de) * 1986-06-30 1988-04-20 Yuko Yoneda Verfahren zur Feststellung spezifisches Protein
US5491098A (en) * 1987-03-09 1996-02-13 Janssen Pharmaceutica N.V. Method for depositing metal particles on a marker
CA1340803C (en) * 1987-03-09 1999-10-26 Janssen Pharmaceutica N.V. Method for depositing metal particles on a marker
USRE38430E1 (en) 1987-03-27 2004-02-17 Becton, Dickinson And Company Solid phase chromatographic immunoassay
EP1248112A3 (de) * 1987-04-27 2004-08-25 Inverness Medical Switzerland GmbH Immunochromatographische Spezifischebindungsassayvorrichtung
US4962023A (en) * 1987-06-22 1990-10-09 Louisiana State University, Agricultural And Mechanical College Single incubation immuno sorbent assay method using particle labels to detect test antigen specific antibodies in presence of other antibodies
US5120643A (en) * 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
JP2581566B2 (ja) * 1987-09-30 1997-02-12 和光純薬工業株式会社 鉄コロイド標識抗体及びその製法並びにこれを用いる組織細胞化学的検出方法
US5006464A (en) * 1987-10-01 1991-04-09 E-Y Laboratories, Inc. Directed flow diagnostic device and method
US5571667A (en) * 1987-10-01 1996-11-05 Chu; Albert E. Elongated membrane flow-through diagnostic device and method
ES2039025T3 (es) * 1987-11-16 1993-08-16 Janssen Pharmaceutica N.V. Un agregado para determinar sustancias combinables.
NL8702769A (nl) * 1987-11-19 1989-06-16 Holland Biotechnology Werkwijze voor het bepalen in een testmonster van componenten van de reactie tussen een specifiek bindend eiwit en de bijbehorende bindbare stof onder toepassing van ten minste een gemerkte component, werkwijze voor het bereiden van de gemerkte component, en testkit voor de bepaling van immunocomponenten.
GB8800702D0 (en) * 1988-01-13 1988-02-10 Nycomed As Test method & reagent kit therefor
US4952517A (en) * 1988-02-08 1990-08-28 Hygeia Sciences, Inc. Positive step immunoassay
US5202267A (en) * 1988-04-04 1993-04-13 Hygeia Sciences, Inc. Sol capture immunoassay kit and procedure
JPH02504429A (ja) * 1988-05-23 1990-12-13 ガイ，ステファン リウマチ様関節炎の診断と治療
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US5079172A (en) 1988-11-04 1992-01-07 Board Of Trustees Operating Michigan State University Method for detecting the presence of antibodies using gold-labeled antibodies and test kit
AU4647589A (en) * 1988-11-10 1990-05-28 Midwest Research Technologies, Inc. Method for electrical detection of a binding reaction
US5202268A (en) * 1988-12-30 1993-04-13 Environmental Diagnostics, Inc. Multi-layered test card for the determination of substances in liquids
US5028535A (en) * 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
EP0401913B1 (de) * 1989-06-05 1995-01-25 Janssen Pharmaceutica N.V. Festphasen-Test zur Verwendung mit einem physikalischen Entwickler
GB8915512D0 (en) 1989-07-06 1989-08-23 Sec Dep For Health Silver enhanced gold-labelled immuno assay method
US5698271A (en) * 1989-08-22 1997-12-16 Immunivest Corporation Methods for the manufacture of magnetically responsive particles
US6352863B1 (en) * 1990-01-19 2002-03-05 La Mina, Inc. Assay device
US5143852A (en) * 1990-09-14 1992-09-01 Biosite Diagnostics, Inc. Antibodies to ligand analogues and their utility in ligand-receptor assays
WO1992012428A1 (en) * 1991-01-11 1992-07-23 Quidel Corporation A one-step lateral flow nonbibulous assay
US5877028A (en) 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
US5998220A (en) 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
US5607863A (en) * 1991-05-29 1997-03-04 Smithkline Diagnostics, Inc. Barrier-controlled assay device
US5468648A (en) * 1991-05-29 1995-11-21 Smithkline Diagnostics, Inc. Interrupted-flow assay device
US5869345A (en) * 1991-05-29 1999-02-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing conductive barrier
CA2130751C (en) * 1992-02-25 2000-01-25 Peter Andersen Apparatus and process for electroelution of a gel containing charged macromolecules
US5395754A (en) * 1992-07-31 1995-03-07 Hybritech Incorporated Membrane-based immunoassay method
US5340746A (en) * 1993-01-08 1994-08-23 Minnesota Mining And Manufacturing Company Composite reactive articles for the determination of cyanide
CA2105515A1 (en) * 1993-09-03 1995-03-04 Carlos A. Santizo Lescaille Visual immunoassay method for the detection of ligands, based on the use of opaque plastic supports
US5712172A (en) 1995-05-18 1998-01-27 Wyntek Diagnostics, Inc. One step immunochromatographic device and method of use
US6319676B1 (en) 1995-05-02 2001-11-20 Carter Wallace, Inc. Diagnostic detection device and method
US5691152A (en) * 1995-11-09 1997-11-25 E. R. Squibb & Sons, Inc. Stable avidin composition
US6551794B1 (en) 1995-11-09 2003-04-22 E. R. Squibb & Sons, Inc. Stable biotinylated biomolecule composition
US5856194A (en) 1996-09-19 1999-01-05 Abbott Laboratories Method for determination of item of interest in a sample
US5795784A (en) 1996-09-19 1998-08-18 Abbott Laboratories Method of performing a process for determining an item of interest in a sample
JP4068677B2 (ja) * 1996-10-25 2008-03-26 アークレイ株式会社 遺伝子の分析方法およびそれに用いる遺伝子分析用キット
JP4025833B2 (ja) * 1996-10-25 2007-12-26 アークレイ株式会社 遺伝子の分析方法およびそれに用いる遺伝子分析用キット並びに遺伝子分析装置
US7153651B1 (en) 1996-10-31 2006-12-26 Inverness Medical - Biostar, Inc. Flow-through optical assay devices providing laminar flow of fluid samples, and methods of construction thereof
US5879951A (en) 1997-01-29 1999-03-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing unidirectional flow
US6103536A (en) 1997-05-02 2000-08-15 Silver Lake Research Corporation Internally referenced competitive assays
US5939252A (en) 1997-05-09 1999-08-17 Lennon; Donald J. Detachable-element assay device
CA2346487A1 (en) * 1998-10-14 2000-04-20 Matthew R. Bonen Immobilized silver immunoassay system
IL126776A (en) * 1998-10-27 2001-04-30 Technion Res & Dev Foundation A method of investing gold
US6136610A (en) 1998-11-23 2000-10-24 Praxsys Biosystems, Inc. Method and apparatus for performing a lateral flow assay
US6136044A (en) * 1999-02-03 2000-10-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Stable coloring by in situ formation of micro-particles
EP1294749A2 (de) * 2000-03-09 2003-03-26 Heska Corporation Rekombinanten antigenen zur bestimmung des immun-zustandes eines tieres
US6699722B2 (en) 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes
DE10108359B4 (de) * 2001-02-21 2008-03-27 Enßlin, Walther, Dr. Nachweisverfahren für reduzierende Substanzen
WO2002100444A1 (en) * 2001-06-08 2002-12-19 Biosphere Medical Inc. Colloidal metal labelled microparticles, their production and use
US20030013084A1 (en) * 2001-07-12 2003-01-16 Berlock Aps Organometallic probe
DE60325564D1 (de) * 2002-03-05 2009-02-12 Univ Texas Biospezifische kontrastmittel
US7138468B2 (en) 2002-03-27 2006-11-21 University Of Southern Mississippi Preparation of transition metal nanoparticles and surfaces modified with (CO)polymers synthesized by RAFT
CA2500407C (en) * 2002-10-11 2009-05-26 Zbx Corporation Diagnostic devices
EP1704405A1 (de) 2003-12-31 2006-09-27 The President and Fellows of Harvard College Testvorrichtung und verfahren
US7638093B2 (en) * 2004-01-28 2009-12-29 Dnt Scientific Research, Llc Interrupted flow rapid confirmatory immunological testing device and method
US7465587B2 (en) 2004-12-03 2008-12-16 Genzyme Corporation Diagnostic assay device
US20060292700A1 (en) * 2005-06-22 2006-12-28 Naishu Wang Diffused interrupted lateral flow immunoassay device and method
KR101255400B1 (ko) 2005-05-23 2013-04-17 파디아 에이비 2 단계 횡 유동 검사 방법 및 장치
US20070015166A1 (en) * 2005-07-14 2007-01-18 Nilsen Thor W Lateral flow methods and devices for detection of nucleic acid binding proteins
WO2007061098A1 (ja) * 2005-11-25 2007-05-31 Japan Science And Technology Agency 分析方法及び分析装置
US11906512B2 (en) 2006-03-31 2024-02-20 Zeus Diagnostics, LLC Integrated device for analyte testing, confirmation, and donor identity verification
US7879623B2 (en) * 2006-03-31 2011-02-01 Guirguis Raouf A Integrated device for analyte, testing, confirmation, and donor identity verification
US7741103B2 (en) * 2006-03-31 2010-06-22 Guirguis Raouf A Integrated screening and confirmation device
US8940527B2 (en) * 2006-03-31 2015-01-27 Lamina Equities Corp. Integrated device for analyte testing, confirmation, and donor identity verification
US7569396B1 (en) 2006-09-08 2009-08-04 Purplecow Llc Caffeine detection using internally referenced competitive assays
US7919331B2 (en) * 2006-12-21 2011-04-05 Silver Lake Research Corporation Chromatographic test strips for one or more analytes
JP4980946B2 (ja) * 2008-02-12 2012-07-18 富士フイルム株式会社 ブロッティング検出方法
JP4870695B2 (ja) * 2008-02-12 2012-02-08 富士フイルム株式会社 メンブレン内の標識を洗浄、増幅、停止する方法
US8673644B2 (en) 2008-05-13 2014-03-18 Battelle Memorial Institute Serum markers for type II diabetes mellitus
WO2010011860A1 (en) * 2008-07-23 2010-01-28 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes
US20100047913A1 (en) * 2008-08-19 2010-02-25 The Trustees Of The University Of Pennsylvania Colloidal Gold Single Reagent Quantitative Protein Assay
EP2391891A1 (de) 2009-01-27 2011-12-07 Proteogenix, Inc. Biomarker zum nachweis neonataler sepsis in einer biologischen flüssigkeit
CA2746128C (en) 2009-01-30 2020-07-28 Pronota N.V. Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof
WO2010132447A2 (en) 2009-05-11 2010-11-18 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
JP5810089B2 (ja) 2009-10-21 2015-11-11 マイカーティス エヌ．ヴェ．ＭｙＣａｒｔｉｓ ＮＶ 体液ホメオスタシスのバイオマーカーとしてのｍｃａｍ
US8663576B2 (en) 2009-11-25 2014-03-04 Hologic, Inc. Detection of intraamniotic infection
AU2011231537B2 (en) 2010-03-26 2016-05-12 Mycartis Nv LTBP2 as a biomarker for renal dysfunction, glomerular filtration rate, dyspnea, acute heart failure, left ventricular hypertrophy, cardiac fibrosis, preeclampsia, pregnancy-associated proteinuria
WO2011128357A2 (en) 2010-04-13 2011-10-20 Pronota N.V. Biomarkers for hypertensive disorders of pregnancy
EP2560005B1 (de) * 2010-04-14 2016-12-07 Nitto Boseki Co., Ltd Testinstrument zur analytmessung in einer probe und verfahren zur analytmessung damit
WO2011150186A1 (en) 2010-05-26 2011-12-01 The Board Of Trustees Of The University Of Illinois Personal glucose meters for detection and quantification of a broad range of analytes
AU2011275753A1 (en) 2010-07-08 2013-01-10 Pronota N.V. Quiescin Q6 as biomarker for hypertensive disorders of pregnancy
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
EP2649454B1 (de) 2010-12-06 2018-06-20 Mycartis N.V. Biomarker und parameter für bluthochdruckleiden während der schwangerschaft
WO2013083781A2 (en) 2011-12-08 2013-06-13 Pronota N.V. Biomarkers and test panels useful in systemic inflammatory conditions
WO2013087887A2 (en) 2011-12-15 2013-06-20 Pronota N.V. Biomarkers and parameters for hypertensive disorders of pregnancy
EP2807271B1 (de) 2012-01-24 2018-08-22 CD Diagnostics, Inc. System zum nachweis einer infektion in der synovialflüssigkeit
US20140248629A1 (en) * 2013-03-03 2014-09-04 Morteza Mahmoudi Gold nanoparticle based dipstick nano-biosensor for detecting plasmodium falciparum and plasmodium vivax and mehtod of synthesizing the same
US9383352B2 (en) 2014-03-26 2016-07-05 Diabetomics, Inc. Salivary protein glycosylation test for diagnosis and monitoring of diabetes
US20180011088A1 (en) 2015-01-29 2018-01-11 Neogen Corporation Methods for Immuno Chromatographic Assay Desensitization
EP3286216B1 (de) 2015-04-23 2022-06-08 Nevada Research & Innovation Corporation Pilznachweis mit mannan-epitop
WO2017023929A1 (en) 2015-08-04 2017-02-09 Cd Diagnostics, Inc. Methods for detecting adverse local tissue reaction (altr) necrosis
US10151749B2 (en) * 2015-08-05 2018-12-11 Alfaisal University Method and kit for the detection of microorganisms
US20200200735A9 (en) 2016-02-22 2020-06-25 Ursure, Inc. System and method for detecting therapeutic agents to monitor adherence to a treatment regimen
US20190120838A1 (en) 2016-04-13 2019-04-25 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and kits for the rapid detection of the escherichia coli o25b-st131 clone
US10564155B2 (en) 2017-01-27 2020-02-18 Raouf A Guirguis Dual swab fluid sample collection for split sample testing and fingerprint identification device
US11061026B2 (en) 2017-02-17 2021-07-13 MFB Fertility, Inc. System of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
KR102582297B1 (ko) 2017-05-19 2023-09-25 필립모리스 프로덕츠 에스.에이. 대상체의 흡연 상태를 구별하기 위한 진단 테스트
WO2019152657A1 (en) 2018-02-03 2019-08-08 Simple Healthkit, Inc. Reliable, comprehensive, and rapid sexual health assessment
US11300576B2 (en) 2019-01-29 2022-04-12 Arizona Board Of Regents On Behalf Of Arizona State University DARPin reagents that distinguish Alzheimer's disease and Parkinson's disease samples

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115198A (en) * 1974-02-11 1978-09-19 Coughlin Robert W Method of immobilization of biologically active organic substances including enzymes
IL49685A (en) * 1976-05-31 1978-10-31 Technion Res & Dev Foundation Specific binding assay method for determining the concentration of materials and reagent means therefor
US4208185A (en) * 1976-08-16 1980-06-17 Mitsubishi Chemical Industries Limited Method and apparatus for the measurement of antigens and antibodies
US4203724A (en) * 1976-08-16 1980-05-20 Mitsubishi Chemical Industries Limited Method and apparatus for the measurement of antigens and antibodies
SE431257B (sv) * 1977-11-03 1984-01-23 Du Pont Sett och anordning for immunanalys med magnetisk metall eller metalloxid som merksubstans
NL7807532A (nl) * 1978-07-13 1980-01-15 Akzo Nv Metaal-immunotest.
US4420558A (en) * 1981-02-12 1983-12-13 Janssen Pharmaceutica N.V. Bright field light microscopic method of enumerating and characterizing subtypes of white blood cells and their precursors
US4487839A (en) * 1983-01-05 1984-12-11 Ortho Diagnostic Systems Inc. Immunoassay methods employing patterns for the detection of soluble and cell surface antigens
CA1260827A (en) * 1984-08-31 1989-09-26 Richard C. Siegel Antibody-metal ion complexes

Also Published As

Publication number Publication date
CA1253422A (en) 1989-05-02
ES8602255A1 (es) 1985-11-01
FI80345B (fi) 1990-01-31
EP0158746B1 (de) 1991-06-12
DK557684A (da) 1985-05-26
JP2601616B2 (ja) 1997-04-16
DE3484710D1 (de) 1991-07-18
ES537926A0 (es) 1985-11-01
NO163754B (no) 1990-04-02
AU583484B2 (en) 1989-05-04
KR890001131B1 (ko) 1989-04-24
AU3582584A (en) 1985-05-30
FI844508A0 (fi) 1984-11-16
JPS60185160A (ja) 1985-09-20
HK14894A (en) 1994-03-04
PT79533A (en) 1984-12-01
IL73607A (en) 1988-12-30
FI80345C (fi) 1992-11-16
NZ210309A (en) 1987-04-30
EP0158746A2 (de) 1985-10-23
ZA849182B (en) 1986-06-25
KR850003728A (ko) 1985-06-26
DK557684D0 (da) 1984-11-23
US4775636A (en) 1988-10-04
NO844672L (no) 1985-05-28
DK160108C (da) 1995-07-24
FI844508L (fi) 1985-05-26
EP0158746A3 (en) 1987-09-23
NO163754C (no) 1993-01-12
IL73607A0 (en) 1985-02-28
CY1759A (en) 1994-07-15
JPH0643998B2 (ja) 1994-06-08
GB8331514D0 (en) 1984-01-04
DK160108B (da) 1991-01-28
JPH0643162A (ja) 1994-02-18

Similar Documents

Publication Publication Date Title
ATE64468T1 (de) Verfahren zur optischen anzeige der direkten oder indirekten bestimmung der reaktion zwischen einem spezifischen bindungsmittel und der korrespondierenden akzeptorsubstanz in ''blot overlay''-testverfahren.
ATE114820T1 (de) Verfahren zur bestimmung von durch onkogene verursachten krebs.
SE8205211D0 (sv) Forfarande for kvantitativ bestemning av en biospecifik affinitetsreaktion
IE850869L (en) Detecting leukocyt s, esterase and protease
ES8609478A1 (es) Un metodo para aumentar la velocidad de hibridacion entre dos segmentos polinucleotidicos complementarios en un medio acuoso.
ES541778A0 (es) Una composicion para determinar la presencia de un analito
CA1267500C (en) COMPOUNDS FOR THE DETECTION OF THE PRESENCE OF HYDROLYTIC SUBSTANCES IN A SAMPLE TO BE ANALYZED
ATA140882A (de) Messverfahren zur ermittlung des massenstromes staubfoermiger und feinkoerniger stoffe
ATE110854T1 (de) Verfahren zur bestimmung von osteocalcin in humanem serum oder plasma.
EP0304794A3 (de) Quantitative Messung des Lithiums
DE68923616D1 (de) Reduzierbare indikatoren, die pyrogallol enthalten und deren verwendung.
GB2245360A (en) Method for monitoring polyacrylic scale inhibitor content
SU834455A1 (ru) Способ косвенного определени ОТНОСиТЕльНОй ОбРАбАТыВАЕМОСТиСТАлЕй пЕРлиТНОгО и фЕРРиТНОгОКлАССОВ
ATE30340T1 (de) Analytisches verfahren und mittel zur bestimmung der protease-hemmungsfaehigkeit von serum.
KR890002666A (ko) 혈청리파제의 측정을 위한 개선된 비탁방법
Golden et al. A radioisotopic study of the effect of surface conditions during wear of Tungsten carbid
DE3679805D1 (de) Homogenes verfahren zum nachweis und/oder zur bestimmung durch lumineszenz eines analyten in einem denselben enthaltenden medium.
RO80976A2 (ro) Instalatie pentru determinarea comportamentului reologic al rocilor tari

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time